Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
196 | 3 | LUNG CANCER//NON SMALL CELL LUNG CANCER//THORAC SURG | 53631 |
2113 | 2 | CRIZOTINIB//ALK//ANAPLASTIC LYMPHOMA KINASE | 5482 |
14602 | 1 | CONTINUAL REASSESSMENT METHOD//DOSE FINDING//DOSE FINDING STUDIES | 789 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | CONTINUAL REASSESSMENT METHOD | authKW | 3150214 | 12% | 87% | 91 |
2 | DOSE FINDING | authKW | 2450953 | 16% | 48% | 128 |
3 | DOSE FINDING STUDIES | authKW | 921767 | 4% | 77% | 30 |
4 | PHASE I TRIAL | authKW | 899905 | 13% | 22% | 104 |
5 | MAXIMUM TOLERATED DOSE | authKW | 845938 | 9% | 30% | 71 |
6 | UP AND DOWN DESIGN | authKW | 397083 | 2% | 76% | 13 |
7 | BAYESIAN ADAPTIVE DESIGN | authKW | 372364 | 2% | 55% | 17 |
8 | ESCALATION WITH OVERDOSE CONTROL | authKW | 359495 | 1% | 100% | 9 |
9 | TRANSLAT PL STAT | address | 332852 | 2% | 56% | 15 |
10 | ADAPTIVE DESIGN | authKW | 332550 | 8% | 12% | 67 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Statistics & Probability | 25482 | 44% | 0% | 345 |
2 | Medical Informatics | 16661 | 18% | 0% | 143 |
3 | Mathematical & Computational Biology | 16155 | 26% | 0% | 209 |
4 | Oncology | 3143 | 34% | 0% | 265 |
5 | Medicine, Research & Experimental | 3090 | 24% | 0% | 190 |
6 | Public, Environmental & Occupational Health | 1138 | 17% | 0% | 131 |
7 | Pharmacology & Pharmacy | 1012 | 23% | 0% | 178 |
8 | Biology | 398 | 7% | 0% | 55 |
9 | Health Care Sciences & Services | 58 | 2% | 0% | 18 |
10 | Computer Science, Interdisciplinary Applications | 24 | 2% | 0% | 17 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | TRANSLAT PL STAT | 332852 | 2% | 56% | 15 |
2 | CNRS UMR8203 | 79888 | 0% | 100% | 2 |
3 | EQUIPE 22UNIV PARIS 5U1138 | 79888 | 0% | 100% | 2 |
4 | MED PHARMACEUT STAT UNIT | 61139 | 2% | 11% | 14 |
5 | EQUIPE ACCUEIL ST PUBL EPIDEMIOL MODELISAT MALA | 59913 | 0% | 50% | 3 |
6 | PAEDIAT ADOLESCENTS YOUNG ADULTS ONCOL | 59913 | 0% | 50% | 3 |
7 | U717 | 57185 | 2% | 11% | 13 |
8 | UNITE 436 | 53257 | 0% | 67% | 2 |
9 | CLIN STUDIES CANC THER EUT | 49156 | 1% | 31% | 4 |
10 | PL DEV SUPPORT DIRECTORATE | 42601 | 1% | 27% | 4 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | STATISTICS IN MEDICINE | 90578 | 16% | 2% | 129 |
2 | PHARMACEUTICAL STATISTICS | 57619 | 4% | 5% | 28 |
3 | JOURNAL OF BIOPHARMACEUTICAL STATISTICS | 42193 | 4% | 3% | 32 |
4 | CLINICAL TRIALS | 39788 | 4% | 4% | 28 |
5 | BIOMETRICS | 20926 | 6% | 1% | 49 |
6 | CONTEMPORARY CLINICAL TRIALS | 15551 | 3% | 2% | 24 |
7 | NATURE REVIEWS CLINICAL ONCOLOGY | 6837 | 1% | 2% | 9 |
8 | CLINICAL CANCER RESEARCH | 5973 | 6% | 0% | 48 |
9 | STATISTICS IN BIOPHARMACEUTICAL RESEARCH | 5899 | 1% | 2% | 7 |
10 | DRUG INFORMATION JOURNAL | 5205 | 2% | 1% | 12 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |